Treatment of hiv-associated nephropathy

AIDS Patient Care and STDs

Volumn 15, Issue 7, 2001, Pages 363-371

  Sothinathan, Renuka ^a   Briggs, William A ^a   Eustace, Joseph A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CORTICOSTEROID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDINAVIR; LAMIVUDINE; PREDNISONE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; PROGNOSIS; SIDE EFFECT; VIRUS LOAD;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GLUCOCORTICOIDS; HIV-1; HUMANS; MALE; PREDNISONE;

EID: 0034945909     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729101750301915     Document Type: Article

References (50)

1. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome
2. The types of renal disease in the acquired immunodeficiency syndrome
3. Renal complications of human immunodeficiency virus type 1
4. Are we missing an epidemic of HIV-associated nephropathy?
5. HIV infection and the kidney
6. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy
7. Course and prognosis of human immunodeficiency virus-associated nephropathy
8. HIV-associated nephropathy: Case study and review of the literature
9. Effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
10. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
11. Angiotensin-converting enzyme inhibition in non-diabetic progressive renal disease: A controlled double-blind trial
12. Captopril and renal survival in patients with human immunodeficiency virus nephropathy
13. Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus associated nephropathy. A case report
14. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy
15. Effect of angiotensin converting-enzyme inhibition on progression of renal disease and mortality in HIV-associated nephropathy
16. Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection
17. Serum angiotensin converting enzyme level is elevated in patients with HIV infection
18. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney
19. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass
20. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection
21. Zidovudine and nephropathy with human immunodeficiency virus (HIV) infection
22. HIV-associated nephropathy: Beneficial effect of AZT therapy
23. Nephropathy associated with infection by human immunodeficiency virus: A report of 11 cases including 6 treated with Zidovudine
24. Zidovudine is beneficial in human immunodeficiency virus associated nephropathy
25. HIV-1-associated nephropathy and response to highly active antiretroviral therapy
26. HIV associated nephropathy and response to highly active antiretroviral therapy
27. Resolution of HIV-associated nephritic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube
28. Protease inhibitors are associated with a slowed progression of HIV-associated nephropathy
29. Long term renal survival in HIV-associated nephropathy (HIVAN) with highly active antiretroviral therapy and angiotensin-converting enzyme inhibitors (ACEI)
30. HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro
31. Human immunodeficiency virus associated glomerulosclerosis
32. Adjunctive corticosteroid therapy for pnemocystis carinii pneumonia in AIDS
33. A controlled trial of early adjunctive treatment with corticosteroids for pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
34. Response to therapy in 37 patients with HIV related thrombocytopenic purpura
35. A pilot study of oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection
36. Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy
37. A steroid responsive nephritic syndrome in a patient with human immunodeficiency virus (HIV) infection
38. Effect of corticosteroid therapy on human immunodeficiency virus associated nephropathy
39. Prednisone improves renal function and proteinuria in human immunodeficiency virus associated nephropathy
40. Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus associated nephropathy
41. Clinical response to prolonged corticosteroids in a patient with human immunodeficiency virus-associated nephropathy
42. HIV-associated nephropathy: Outcome and prognosis factors
43. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids
44. Role of bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice
45. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy
46. Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome
47. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice
48. Pathology of HIV associated nephropathy: A detailed morphologic and comparative study
49. Human immunodeficiency virus infection and nephrotic syndrome
50. Macrophages in human immunodeficiency virus associated kidney diseases